SOURCE: Leerink Swann & Company

October 30, 2006 14:48 ET

Daniel B. Dubin, M.D. Promoted to Vice Chairman of the Investment Banking Firm of Leerink Swann & Company

BOSTON, MA -- (MARKET WIRE) -- October 30, 2006 -- Daniel B. Dubin, M.D. has been promoted to Vice Chairman of the Boston-based firm. Dan is a founder and previously had been President of MEDACorp, a Leerink Swann subsidiary providing biomedical consulting services to life sciences companies and the investment community. In this new role, Dr. Dubin's focus will be to activate the deep domain expertise resident at MEDACorp and Leerink Swann & Company to best serve Leerink Swann's growing list of investment banking clients. "This promotion is exemplary of our strategic goal of transforming the Firm into a world-class healthcare investment bank. Dr. Dubin and the MEDACorp platform will be focused on providing proprietary insight to our corporate clients," said Jeffrey A. Leerink, CEO and Chairman of Leerink Swann.

"We are very pleased to have Dan devote his energies to the investment banking team's efforts. His reputation in the healthcare and life sciences areas is well-known and respected," added David Ogens, Senior Managing Director, Head of Investment Banking.

Prior to joining Leerink Swann, Dr. Dubin was an instructor in Dermatology at Harvard Medical School and has held staff appointments at the Brigham and Women's Hospital and Dana Farber Cancer Institute. While at Brigham and Women's Hospital, he served as Ambulatory Medical Director of Clinical Dermatology and as a member of the Clinical Executive Committee. He is a graduate of Dartmouth College and Harvard Medical School and completed both an internship in internal medicine and a residency in Dermatology at Massachusetts General Hospital. Dr. Dubin has published over 30 manuscripts in medical journals and textbooks and performed a NIH training fellowship at the Harvard Skin Disease Research Center.

About Leerink Swann & Company

Leerink Swann & Company is a Healthcare Investment Bank that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company has been voted the Best Boutique Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty by Institutional Investor for the past four years. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    Jeffrey A. Leerink
    Leerink Swann & Company
    (617) 918-4810